相关实验视频

Updated: Sep 11, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

膀癌中的核受体:对miRNA介导调节和潜在的治疗影响的洞察

José Javier Flores-Estrada¹, Adriana Jiménez¹, Georgina Victoria-Acosta¹

¹División de Investigación, Hospital Juárez De México, Mexico City 07760, Mexico.

International journal of molecular sciences

|August 14, 2025

概括

核受体 (NR) 和微RNA (miRNA) 在膀癌 (BCa) 中形成复杂的调节网络. 了解这些相互作用为精密瘤学和改善治疗结果提供了新的目标.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
基因规则基因规则

背景情况:

核受体 (NR) 是关键的转录因子,参与生理过程和癌症.
在膀癌 (BCa) 中,失调的NR信号影响瘤的启动,进展,抵抗和免疫逃避.
新出现的证据显示,在BCa病变发生过程中,NRs和microRNAs (miRNAs) 之间存在显著的交叉声.

研究的目的:

在BCa中提供NRs和miRNAs之间的分子相互作用的综合概述.
阐明miRNAs如何调节NR表达和功能,反之亦然.
突出针对这些NR-miRNA网络的治疗策略.

主要方法:

文献综述侧重于BCa中NRs和miRNAs之间的分子相互作用.
通过NR-miRNA相互作用形成的调节反循环的分析.
讨论影响关键癌症特征的特定miRNA-NR相互作用.

主要成果:

miRNAs调节NR表达和功能,而NRs影响miRNA生物发生,创造反循环.
特定的相互作用会影响表皮细胞到介质细胞的过渡,代谢重编程,血管生成和化学抵抗.
NR-miRNA网络与BCa进展和治疗耐药性有关.

结论:

NR-miRNA相互作用是BCa发展和进展的核心.
针对这些网络提供了新的诊断生物标志物和个性化治疗的潜力.
进一步了解可以促进尿道癌症的精确瘤学.

关键词:

基于RNA的治疗方法膀癌:膀癌是一种癌症.基因调节基因调节基因调节这就是miRNAs.核受体是一种核受体.治疗反应的治疗反应.

更多相关视频

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...

Transducer Mechanism: Nuclear Receptors

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...